Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherPerspective

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. Wrighton
Drug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Thorir D. Bjornsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John T. Callaghan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi J. Einolf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Volker Fischer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Gan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Grimm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Kao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Peter King
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Miwa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan Ni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gondi Kumar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James McLeod
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Obach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley Roberts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Roe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita Shah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fred Snikeris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John T. Sullivan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Tweedie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose M. Vega
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Walsh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven A. Wrighton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 7 815-832
DOI 
https://doi.org/10.1124/dmd.31.7.815
PubMed 
12814957

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received January 14, 2003
  • Accepted March 19, 2003
  • Published online July 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Thorir D. Bjornsson,
  2. John T. Callaghan,
  3. Heidi J. Einolf,
  4. Volker Fischer,
  5. Lawrence Gan,
  6. Scott Grimm,
  7. John Kao,
  8. S. Peter King,
  9. Gerald Miwa,
  10. Lan Ni,
  11. Gondi Kumar,
  12. James McLeod,
  13. R. Scott Obach,
  14. Stanley Roberts,
  15. Amy Roe,
  16. Anita Shah,
  17. Fred Snikeris,
  18. John T. Sullivan,
  19. Donald Tweedie,
  20. Jose M. Vega,
  21. John Walsh and
  22. Steven A. Wrighton
  1. Abbott Laboratories, Abbott Park, Illinois (S.R.), Amgen Inc., Thousand Oaks, California (G.K., J.T.S.), AstraZeneca Pharmaceuticals LP, Wilmington, Delaware (S.G.), Aventis, Bridgewater, New Jersey (S.P.K.), Bayer Corporation, West Haven, Connecticut (A.S.), Boehringer Ingelheim Corporation, Ridgefield, Connecticut, (D.T.), Eli Lilly and Company, Indianapolis, Indiana (J.T.C., L. N., S.A.W.), GlaxoSmithKline, Research Triangle Park, North Carolina (J.W.), Merck Research Laboratories, West Point, Pennsylvania (J.M.V.), Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts (L.G., G.M.), Novartis Pharmaceuticals Corporation, East Hanover, New Jersey (H.J.E., V.F., J.M.), Pfizer Inc., Groton, Connecticut (R.S.O.), Procter & Gamble, Cincinnati, Ohio (A.R.), Sanofi-Syntelabo Inc., Malvern, Pennsylvania (F.S.), Wyeth, Collegeville, Pennsylavnia (T.D.B., J.K.)
  1. Address correspondence to:
    Volker Fischer, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07836-1080. E-mail: volker.fischer{at}pharma.novartis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 20177416793
Sep 20176621285
Oct 201711133364
Nov 201711318756
Dec 2017778433
Jan 20188615872
Feb 20188519955
Mar 2018118307103
Apr 20188073577
May 201861553107
Jun 20183936564
Jul 20185827885
Aug 20186018279
Sep 20185016080
Oct 20186924673
Nov 20185929477
Dec 20183519241
Jan 20193402123
Feb 20192962422
Mar 20193213917
Apr 20192312617
May 20191721712
Jun 20191261714
Jul 2019116179
Aug 20191431511
Oct 20191583917
Nov 20191901410
Dec 20191483212
Jan 20201442211
Feb 20202001914
Mar 20204635015
May 202022995
Jun 20201951613
Jul 202016889
Aug 2020901821
Sep 20201211617
Oct 20203624018
Nov 2020204146
Dec 2020181197
Jan 20211458911
Feb 2021167856
Mar 20213504319
Apr 20211681714
May 2021144308
Jun 20211725411
Jul 20211082711
Aug 2021112506
Sep 2021119335
Oct 20211162710
Nov 20212052815
Dec 20211483017
Jan 20221172415
Feb 20221591511
Mar 20223523220
Apr 20221692813
May 2022130137
Jun 20221021412
Jul 20221171810
Aug 2022113299
Sep 2022160909
Oct 202216847713
Nov 2022149409
Dec 2022148179
Jan 2023189199

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (7)
Drug Metabolism and Disposition
Vol. 31, Issue 7
1 Jul 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherPerspective

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. Wrighton
Drug Metabolism and Disposition July 1, 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherPerspective

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. Wrighton
Drug Metabolism and Disposition July 1, 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • In Vitro Drug-Drug Interaction Studies
    • In Vivo Drug-Drug Interactions
    • Concluding Remarks
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Regulatory Guidance for P450 Induction from IQ: Part 3
  • Prioritizing NPs as precipitants of NPDIs
  • Regulatory Guidance for P450 Induction from IQ
Show more PERSPECTIVES

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics